Skip to main content
. 2022 Oct 20;13:1018093. doi: 10.3389/fendo.2022.1018093

Table 1.

Eligible criteria based on PICOS.

Inclusion criteria Exclusion criteria
Participant Patients with DKD diagnosed clinically or biopsy-proven DN Patients receiving dialysis; patients with diabetes and other chronic kidney disease
Exposure DKD/DN
Comparator DKD vs. Non-DKD, including diabetes mellitus, non-diabetic kidney disease, and healthy controls
Outcomes Gut microbial diversity and composition Insufficient data for analysis; not high-throughput sequencing technology for detecting gut microbiome
Study design Observational study

DKD, diabetic kidney disease; DN, diabetic nephropathy.